Vaso Operating Income 2010-2024 | VASO

Vaso operating income from 2010 to 2024. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.

Vaso Operating Income 2010-2024 | VASO

Vaso operating income from 2010 to 2024. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
Related Stocks
Company NameMarket
Cap
Thermo Fisher Scientific (TMO)$202.3B
Intuitive Surgical (ISRG)$191.3B
Edwards Lifesciences (EW)$44.5B
Alcon (ALC)$42.5B
IQVIA Holdings (IQV)$36.3B
IDEXX Laboratories (IDXX)$33.9B
DexCom (DXCM)$31.3B
Waters (WAT)$22.2B
STERIS (STE)$20.6B
SONOVA HOLDING (SONVY)$19.8B
Hologic (HOLX)$16.5B
Fresenius Medical Care AG KGaA (FMS)$13.3B
Sysmex ADR (SSMXY)$11.7B
Globus Medical (GMED)$11.4B
Penumbra (PEN)$9.2B
Masimo (MASI)$9B
Glaukos (GKOS)$8.3B
Teleflex (TFX)$8.2B
Integer Holdings (ITGR)$4.5B
PROCEPT BioRobotics (PRCT)$4.4B
Veracyte (VCYT)$3.2B
Inari Medical (NARI)$3.1B
LivaNova (LIVN)$2.5B
Tandem Diabetes Care (TNDM)$2.4B
Nihon Kohden (NHNKY)$2.4B
TransMedics (TMDX)$2.1B
Elekta AB (EKTAY)$2B
Integra LifeSciences Holdings (IART)$1.7B
RxSight (RXST)$1.4B
Alphatec Holdings (ATEC)$1.3B